Conclusions and Relevance: The current evidence underscores the potential of GLP-1 RAs as a novel therapeutic approach for certain psychiatric disorders, particularly alcohol-related disorders, depression, and autism-related food behaviors
In Their Own Words In recent years, GLP-1 receptor agonists like semaglutide (sold under brand names Ozempic and Wegovy) have become revolutionary treatments for obesity and type 2 diabetes, offering substantial weight loss, and myriad other benefits including improved renal and cardiovascular health
Severe Nausea and Vomiting For some, the sickness doesnt ease over time and leads to dehydration or malnutrition
One expert who gave evidence to Nice, Prof John Wilding, who leads the clinical research on obesity at Liverpool University, was president of the World Obesity Federation when he recommended Wegovy for use on the NHS
As she shared: "Every single person that came to me said, 'I am an athlete
But nobody talks much about what happens when it goes wrong. For more stars who have detailed their experience with GLP-1s, read on For the latest breaking news updates, click here to download the E